feed,title,long_url,short_url
Investors,"Roivant Leaps Into A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease",https://www.investors.com/news/technology/roivant-sciences-autoimmune-disease-test-results/,
Investors,"Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker",https://www.investors.com/news/technology/oruka-therapeutics-biotech-stock-psoriasis-treatment/,
